BioCentury
ARTICLE | Company News

Dainippon Sumitomo, GlaxoSmithKline sales and marketing update

January 30, 2012 8:00 AM UTC

The companies will co-market GlaxoSmithKline's 12.5 and 25 mg Paxil CR paroxetine in Japan starting April 1. Earlier this month, the Japanese Ministry of Health, Labor and Welfare (MHLW) approved the...